Transformed Non-Hodgkin Lymphoma Not Yet Recruiting Phase 2 Trials for Vincristine (DB00541)

IndicationStatusPhase
DBCOND0115816 (Transformed Non-Hodgkin Lymphoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03749018Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's LymphomaTreatment